Daniel Getman joins Sucampo's board
This article was originally published in Scrip
Executive Summary
Sucampo Pharmaceuticals has elected Dr Daniel Getman to its board of directors. Dr Getman is currently president of the Kansas City Area Life Sciences Institute, and was previously vice-president of Pfizer global research and development and director of Pfizer's St Louis laboratories. Dr Getman joins Sucampo as Andrew Ferrara, a director since July 2008, resigns.